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Background: Fetal alcohol syndrome (FAS) belongs to the umbrella of fetal alcohol spectrum
disorders (FASD) and affects 0.02e0.8% of all annual births with a high number of unde-
tected cases. FAS has severe and life determining consequences for the affected individual
and his family.
Aim: The aim of the German guideline version 2013 is to provide objectively evaluated,
evidence-based, clinically relevant and easily applicable diagnostic criteria for the full
picture FAS.
Methods: A systematic literature review (2001e2011), analysis of international guidelines
and focused hand search were performed. Based on the evidence-assessed literature the
multidisciplinary guideline group (14 German Professional Societies, the patient support
group “FASD Germany” and 15 additional experts) consented recommendations for the
diagnosis of FAS.
Results: The following diagnostic criteria for FAS resulted: at least one deficit of growth,
three defined facial characteristics and one functional or structural anomaly of the central
nervous system. Confirmation of intrauterine alcohol exposure is not considered as a
prerequisite for FAS diagnosis.
Conclusion: The German guideline presented here constitutes an unbiased evidence-based
approach to the diagnosis of patients with fetal alcohol syndrome. It includes a practical
pocket guide FAS for a quick overview of the diagnostic workup in everyday clinical work.
ª 2013 European Paediatric Neurology Society. Published by Elsevier Ltd.
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are summarized under the term fetal alcohol spectrum dis-
order (FASD). FASD includes fetal alcohol syndrome (FAS),
partial fetal alcohol syndrome (pFAS), alcohol related neuro-
developmental disorders (ARND) and alcohol related birth
defects (ARBD).
The work we present here is a first step in developing
criteria for diagnosis of the full range of FASD. Here we focus
on the development of criteria for the full picture of FAS only
and not for the other three categorical diagnoses of FASD.
Fetal alcohol syndrome (FAS) is a common and often not
recognized disorder. It is completely avoidable. According to
the international literature of the last 10 years the prevalence
of FAS ranges from 0.2 to 8.2 per thousand births. The annual
birth rate in Germany is approximately 678,000. That means
that 130 to 5400 babies with FAS are born in Germany every
year. Consequently 2340 to 97,200 children and adolescents
(0e18 years of age) actually live in Germany andmost of them
are undiagnosed.
FAS has severe consequences not only for the affected in-
dividual and his or her family but also for the immediate
developmental and educational environment and for the
health and social systems in general.
FAS can be seen as a “toxic static encephalopathy”. While
the cerebral damage due to intrauterine alcohol exposure is
irreversible, the impairment of functioning in every-day life
changes during development and can be positively influenced
by early conceptualization and individually appropriate
stimulation and training (e.g. Ref.1). Thus FAS also meets the
classical criteria for a “developmental disorder”.
The German guideline presented here provides evidence-
based, clinically relevant and in practice easily applicable
diagnostic criteria and recommendations for the identifica-
tion of FAS in children and adolescents.
Implementation of this Guideline will be a first step to in-
crease awareness in the (German) society for the severe
complications of intrauterine alcohol exposure with the aim
to reduce the prevalence of alcohol consumption during
pregnancy and thereby diminish the incidence of FAS.
Furthermore this guideline should assist in providing early
and individual support and treatment of affected patients andother fetal alcohol spectrum disorders (partial FAS, ARND and
ARBD) is planned.2. Methods
The German Federal Ministry of Health (GFMOH) initiated and
partly financed this guideline project which was coordinated
by the first and last author. The funding by the GFMOH did not
influence the content of the guideline in any way.
In 2011, a guideline consensus group was established
including representatives of the German Federal Ministry of
Health, the German Scientific Societies and Professional As-
sociations, the national Patient Support Group FASD Germany
as well as additional FAS experts (Table 1).
Systematic retrieval of the literature and determination
of levels of evidence (according to the Oxford Classification
System 2009) were conducted by the guideline steering
group in Munich and the AQuMed (German Agency for
Quality in Medicine). The AWMF (Association of the Scien-
tific Medical Societies) was responsible for the methodolog-
ical guidance.
The key question for the systematic literature review was:
Which development-related criteria enable the diagnosis of
FAS in childhood and adolescence (0e18 years of age)?
The search included English and German literature pub-
lished between January 1, 2001 and October 31, 2011 (search
strategy and previously defined criteria for inclusion and
exclusion of abstracts and publications see ePub: Tables 1 and
2). Full text publications included for evaluationwere assessed
for the levels of evidence provided using the Oxford Evidence
Classification System 2009 (ePub: Table 3).
According to the level of evidence provided in the literature
(from LoE 1 to LoE 5), a grade of recommendation (from the
strongest recommendation A “we recommend” to the strong
recommendation B “we suggest” to the recommendation
grade C “may be considered”) was proposed by the guideline
coordinators according to the schema of the German Associ-
ation of the Scientific Medical Societies (Fig. 1). Depending on
the clinical relevance, ethical considerations and practica-
bility of the diagnostic criteria the multidisciplinary guideline
group discussed and if required adapted the proposed grades
Table 1 e Members of the guideline-consensus-group.
German scientific societies and professional associations Representatives
German Society of Pediatrics and Adolescent Medicine Prof. Florian Heinen, MD
Society of Neuropediatrics Prof. Florian Heinen, MD
German Society of Social Pediatrics and Adolescent Medicine Juliane Spiegler, MD
German Society of Gynecology and Obstetrics Prof. Franz Kainer, MD
German Society of Neonatology and Pediatric Intensive Care Prof. Rolf F. Maier, MD
German Society of Child and Adolescent Psychiatry,
Psychosomatics and Psychotherapy
Prof. Frank Ha¨ßler, MD
German Society of Addiction Research and Addiction Treatment Regina Rasenack, MD
German Society of Addiction Psychology Prof. Tanja Hoff
German Society of Addiction Medicine Gerhard Reymann, MD
German Society of Midwifery Science Prof. Rainhild Scha¨fers, MD
German Association of Midwives Regine Gresens
German Association of Psychologists Laszlo A. Pota
German Association of Pediatricians Nikolaus Weissenrieder, MD
German Association of Physicians of the Public Health Services Gabriele Trost-Brinkhues, MD
Function Experts
Director of the children’s home Sonnenhof Gela Becker
Bavarian Academy of Addiction and Health Questions Beate Erbas, MD
FASD Center, University of Mu¨nster Reinhold Feldmann
Neonatology und Neuropediatrics, Ludwig Maximilians University Munich Anne Hilgendorff, MD
Medical Director of the KMG Rehabilitation Center Su¨lzhayn Heike Hoff-Emden, MD
Board Member of the German Society of Social Pediatrics and Adolescent Medicine Ulrike Horacek, MD
Director of the German Association of the Scientific Medical Societies (AWMF-IMWi) Prof. Ina Kopp, MD (nonvoting)
FASD Center, Neuropediatrics, Ludwig Maximilians University Munich Mirjam Landgraf, MD
President of the Patient Support Group FASD Germany Gisela Michalowski
Board Member of the Patient Support Group FASD Germany Veerle Moubax
German Agency for Quality in Medicine (AQuMed) Monika Nothacker, MD (nonvoting)
Youth Welfare Office Munich Carla Pertl
Institute of Medical Information Processing, Biometrics and Epidemiology,
Ludwig Maximilians University Munich
Eva Rehfueß (nonvoting)
Department for Health and Environment of the capital Munich,
Health prevention for children and adolescents
Monika Reincke, MD
Neonatology, Ludwig Maximilians University Munich Andreas Ro¨sslein
Advocate for Child and Adolescent Rights Gila Schindler
Medical Director of Neonatology, Ludwig Maximilians University Munich Prof. Andreas Schulze, MD
Child and Adolescent Psychiatry, FASD Center, Heckscher Clinics, Munich Martin Sobanski, MD
FASD Center, Charite´ University Berlin Prof. Hans-Ludwig Spohr, MD
Child and Adolescent Psychiatry, FASD Center, Heckscher Clinics, Munich Penelope Thomas
FASD Center, Charite´ University Berlin Jessica Wagner
Board Member of the Patient Support Group FASD Germany Wendelina Wendenburg, MD
Fig. 1 e Consensus process based on the evidence-
assessed literature.
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independent methodologically experienced moderator (Prof.
Ina Kopp, MD), formal consensus was obtained in the course
of a nominal group process at three multidisciplinary
consensus meetings (2011 and 2012).3. Results
The systematic search in Pubmed resulted in 1363 and in the
Cochrane Library in 20 hits. After application of the inclusion
and exclusion criteria 178 full text publications were included
for the assessment of evidence (ePub: Fig. 1).
The formal consensus process based on the evidence-
assessed literature led to seven key recommendations for
the diagnosis of FAS in children and adolescents (Table 2).
Background information and additional recommendations for
the performance of the key recommendations are given.
Table 2 e Key recommendations for the diagnosis of FAS.
Diagnostic recommendations Level of evidence Grade of recommendation
First key recommendation: For the diagnosis of FAS the following abnormalities in
all four diagnostic fields should be present:
1. Growth deficits
2. Facial characteristics
3. Abnormalities of the central nervous system (CNS)
4. Confirmed or unconfirmed intrauterine alcohol exposure
Expert consensus
Second key recommendation: For the diagnostic field “Growth deficits”
at least one of the following abnormalities, adapted to gestational age,
age and gender, documented at any time, should be present:
1. Birth weight or body weight  10th percentile
2. Birth length or body length  10th percentile
3. Body mass index  10th percentile
2 A
Strong consensus
Third key recommendation: For the diagnostic field “Facial characteristics”
the following three facial abnormalities should be present simultaneously
and may be present at any age:
1. Short palpebral fissure length (3rd percentile)
2. Smooth philtrum (Rank 4 or 5 Lip-Philtrum-Guide)
3. Thin upper lip (Rank 4 or 5 Lip-Philtrum-Guide)
1 A
Strong consensus
Fourth key recommendation: For the diagnostic field “Abnormalities of the central
nervous system” (CNS) at least one of the following criteria should be found:
1. Functional abnormalities of the CNS
2. Structural abnormalities of the CNS
Expert consensus
Fifth key recommendation: For the criteria “Functional CNS abnormalities”
at least one of the following deficits, that is not adequate for age and that
cannot be explained solely by the familial background or social
environment should be found:
1. Global intellectual deficit at least two standard deviations below the mean
or significant combined developmental delay of children under the age of two
years (if measurable by a standardized test at least two standard deviations
below the mean).
2. Performance at least two standard deviations below the mean in at least three
of the following domains or in at least two of the following domains combined
with epilepsy:
Language/speech;
Fine motor functions;
Spatial-visual perception or spatial-constructive skills;
Learning or memory skills;
Executive functions;
Arithmetic skills;
Attention;
Social skills and behavior
2e4 B
Consensus
Sixth key recommendation: For the criteria “Structural CNS abnormalities”
the following anomaly adapted to gestational age, age and gender, documented
at any time, should be found:
Microcephaly  10th percentile/3rd percentile
2 B
Strong consensus
Seventh key recommendation: if there are abnormalities in the three other diagnostic
fields the diagnosis of FAS should be made even when confirmation of maternal
alcohol consumption during pregnancy is lacking.
3 A
Consensus
e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 1 7 ( 2 0 1 3 ) 4 3 7e4 4 6440All recommendations, except for the cut-off percentile of
the head circumference for the children and adolescents with
FAS, were adopted with “strong consensus” (agreement by
>95% of the participants) or “consensus” (agreement by >75%
of the participants).3.1. Background information on the first key
recommendation: diagnostic fields of FAS
The diagnosis of FAS in childhood is very important because
early diagnosis is a prerequisite for conceptualization, early
support and treatment of the patient and thus for a betteroutcome regarding independent living and working life in
adulthood.1
Only the FAS facial phenotype is acceptable as screening
method for FAS.2 Criteria in all other diagnostic fields are not
specific for patients with FAS.
The diagnostic criteria of FAS are difficult to apply to
newborns. The facial features and growth impairments
attenuate with age for some patients. Alternatively, the
neuropsychiatric manifestations of FAS increase with age
meaning that the severity of symptoms tends to increase as
does the number of comorbid conditions.
Any professional working in the health or social care sys-
tem for children who finds abnormalities in one of the
Fig. 2 e Lip-Philtrum Guide (ª 2013 Susan Astley PhD,
University of Washington).
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diagnostic fields or refer their assessment to other pro-
fessionals with appropriate qualifications (expert consensus).
Professionals including nurses, midwives, social education
workers, physio-, speech- and occupational therapists, psy-
chologists, psychotherapists, physicians in gynecology and
obstetrics, pediatricians including neonatology, intensive
care, pediatric neurology, developmental medicine, child and
adolescent psychiatry, general medicine and public health
services should be sensitized for the clinical appearances of
FAS and should be encouraged to communicate any reason-
able suspicion of FAS and to initiate the necessary diagnostic
process.
The content of these recommendations is not to be taken
for granted as most of the individuals with FAS in Germany
are undiagnosed.
The diagnosis of FAS should involve at least a medical
doctor and a psychologist. Where very young children are
concerned the evaluation should involve a developmental
neurologist. A multimodal and interdisciplinary assessment
of the child suspected of FAS is strongly recommended (expert
consensus).
3.2. Background information on the second key
recommendation: growth deficits
Klug et al.3 found that children with FAS have a significantly
lower weight and length at birth or in childhood when
compared to childrenwithout FAS. They also showed that 22%
of the children with FAS had a body mass index below the 3rd
percentile in comparison with 3% of the children without FAS
(LoE 2c). Day et al.4 reported in 2011 that 14-year-old children
whose mothers drank alcohol during the first and second
trimester of pregnancy had a reduced body weight and those
whose mothers consumed alcohol in the first trimester had a
diminished body length (LoE 2b). The recommendations of the
guideline group regarding abnormalities of growth are pre-
dominantly based on these two studies.
Growth deficiencies which can be explained solely by fa-
milial small body length, constitutional growth retardation,
prenatal nutritional deficiencies, skeletal dysplasia, hormonal
dysfunctions, genetic syndromes, chronic diseases, malab-
sorption, malnutrition or neglect should be excluded (expert
consensus).
3.3. Background information on the third key
recommendation: facial characteristics
The FAS-specific facial features sometimes become less
distinctive in adolescents or young adults. If the three specific
facial characteristics of FAS can be found on photos of these
patients at younger age the criteria for “facial characteristics”
are fulfilled even if these patients don’t show the specific
features at older age (expert consensus).
Already in 1976 Jones et al.5 reported that children who
suffer from intrauterine alcohol exposure have typical facial
characteristics. This was confirmed in 1987 in a caseecontrol-
study (LoE 4) by Clarren et al.6 Based on a validation cohort
study (LoE 1) Astley and Clarren2 could show in 1995 that FAS
is associated with a specific combination of facial features.This study with direct measurements on the patient’s face
shows that independent of ethnicity (Caucasian, African and
Asian) and gender the best discriminating features for FAS are
a short palpebral fissure length, a smooth philtrum and a thin
upper lip. The facial screening used by Astley and Clarren in
their study had a sensitivity of 100% and a specificity of 89.4%.
Using a computerized measurement of facial photos7 the
screening for FAS with the combination of the three facial
characteristics smooth philtrum, thin upper lip and short
palpebral fissures (see Fig. 2) reached a positive predictive
value of 85.7%, a sensitivity of 100% and a specificity of 99.8%.
The screening via 3D-laser scanner did not improve diag-
nostic certainty for children with FAS (Ref.8 LoE 2, Ref.9 LoE 2).
For a quantitative assessment of the upper lip and the
philtrum, Astley and Clarren10,11 developed a lip-philtrum
guide with five facial photos that correspond to a five-point
Lickert scale. Measurements of four or five points on this
scale show FAS-typical pathological grades for the philtrum
and upper lip (see Fig. 2).
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of the patient can be used as a reference point on photos to
measure the palpebral fissure length (see Fig. 3). Astley and
Kinzel developed a computer program to measure the palpe-
bral fissure length on photos (Fetal Alcohol Syndrome Facial
Photographic Analysis Software, Version 2.0.0. Seattle (WA):
University of Washington; http://depts.washington.edu/
fasdpn/htmls/face-software.htm). Another possibility to
measure the palpebral fissure is the direct measurement on
the patient with a transparent ruler. It has to be taken into
account that sometimes the measurements from pictures
differ from those of living patients. The measurement of
palpebral fissure length is complex. When one examines the
normative charts of this feature it becomes clear that at some
ages a 1 mm difference can change the child’s percentile rank
by over 8 percentile ranks.
Clarren et al.12 recently developed percentiles for the
palpebral fissure length based on measurements of the
palpebral fissures of 2097 healthy Canadian girls and boys
from 6 to 16 years of age (2010, LoE 2b). In 2011 Astley et al.13
confirmed in a validation study for the Canadian palpebral
fissure length percentiles that the palpebral fissure lengths of
healthy American children of Caucasian and Asian ethnicity
(n¼ 90) were within themean of the Canadian percentiles and
that American children with FAS (n ¼ 22) had palpebral fissure
lengths at least two standard deviations below the Canadian
mean (LoE 2b-). The Canadian percentiles do not fit for chil-
dren with African ethnicity.
Percentiles for the palpebral fissure length according to
Thomas et al.14 and Hall et al.15 gave standard values for
children from birth on but probably overestimate the palpe-
bral fissure lengths in the normal population.13
For children under the age of six years, percentiles by
Stro¨mland et al.16 can be used.
The German guideline group suggests the use of the Ca-
nadian palpebral fissure length percentiles for German chil-
dren aged 6e16 years with suspected FAS (LoE 2b-
/ Recommendation Grade B) and the measurement of the
upper lip and philtrum with the Lip-Philtrum Guide for chil-
dren of any age (LoE 1b-/ Recommendation Grade A).3.4. Background information on the fourth key
recommendation: abnormalities of the central nervous
system
The toxic brain damage can primarily manifest as patholog-
ical growth of the brain and therefore of the scull (percentile of
the head circumference). The damage can also be shown in
micro- or macrostructural abnormalities of the brain. These
are described in several recent studies that currently however
don’t reach consistent sufficient evidence.Fig. 3 e Measurement of the palpebral fissure length (CIn everyday life the affected children and adolescents
impress with multiple significant functional CNS abnormal-
ities that result from the toxic damage. The clinical and
behavioral phenotype with deficits in functional CNS domains
can be determined by neurological and neuropsychological
assessments.3.5. Background information on the fifth key
recommendation: functional CNS abnormalities
The determination of the affected functional brain domains is
based on the studies shown in ePub: Table 4.
Most of these studies concerning functional CNS abnor-
malities in children with FAS are explorative caseecontrol-
studies that reach a low level of evidence of 4. Because of
small case numbers, lack of blinding of the assessors, no
adjustment formultiple testing, no validation on independent
collectives, and inadequate consideration of confounders,
incidental results cannot be ruled out. The study of Nash
et al.17 regarding attention, social skills and behavior has a
better level of evidence of 3. The publication of Coles et al.18
also evaluates the functional domain “attention” and rea-
ches an LoE of 3. Both studies assess the differentiation be-
tween children with FAS and children with attention-deficit-
syndrome. The background is that children with FAS are
often incorrectly diagnosed only with attention-deficit-
syndrome while the underlying alcohol toxic brain damage
remains unrecognized.
Adaptive behavior may be one of the most important
measures across the age span, especially for older children
with IQ above 70.
In summary, no specific neuropsychological profile of
children with FAS can be defined because of methodological
weaknesses of the available studies.
Therefore, the guideline group gives additional consensus-
based recommendations for functional CNS-diagnosis: it is
emphasized that functional CNS abnormalities should be
assessed with standardized neuropsychological tests or in-
struments and a psychological or medical evaluation of
behavior for the diagnosis of FAS in children and adolescents
(expert consensus).
Clear identification of deficits in each of the functional CNS
subdomains is essential not only for the diagnosis of FAS but
also in order to provide appropriate individual support and
training aimed to improve the level of functioning in everyday
life and the quality of life of the affected children and their
families. Therefore, a sophisticated and complex psychologi-
cal assessment has a very important role in the diagnostic
process for FAS.
For very young patients up to toddler age it is difficult if not
impossible to determine functional deficits in subdomains.opyright Mirjam Landgraf, University of Munich).
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mostly consists of developmental delay and therefore re-
quires examination by an experienced developmental
neurologist (expert consensus). The inclusion of a standard-
ized developmental test in the diagnostic process is
preferable.
Because the alcohol-induced damage of the brain may be
either general or multifocal, the patient should show deficits
in at least three domains to establish the diagnosis of FAS
(expert consensus).
Bell et al.19 showed in their study of 2010, that 11.8% of
children and adults with FASD (n ¼ 425) had one or more ep-
isodes of seizures and 5.9% suffered from epilepsy (LoE 2). In
2010 Astley20 examined 1400 individuals with confirmed pre-
natal alcohol exposure and found a prevalence of seizures
among the subset of patients with FAS of 6.5% (10/154).
Although there were no control groups in these studies these
prevalences for epileptic activity are considerably higher than
in the normal population (prevalence of epilepsy ca.
0.4e0.8%21). Therefore, for the diagnosis of FAS, epilepsy
combined with deficits in two neuropsychological domains
fulfils the criteria “Functional CNS abnormalities” (LoE
2/ Recommendation Grade B).
3.6. Background information on the sixth key
recommendation: structural CNS abnormalities
Day et al.4 showed in their study (n ¼ 565) in 2002 that the
head circumferences of children whose mothers consumed
alcohol during pregnancy (first trimester 64.6%, second
trimester 31.9%, third trimester 75.5%) was significantly
smaller than those of the children without intrauterine
alcohol exposure (LoE 2). The absolute difference at the age of
14 years was 6.6 mm. Confounders were maternal body
length, race, gender, nicotine use, hospital stays and number
of siblings. In 2006 Handmaker et al.22 found in prenatal ul-
trasound examinations (n ¼ 167) that, compared with fetuses
of mothers who stopped drinking alcohol after pregnancy
recognition, fetuses whose mothers did not stop (52.1%) had
no smaller head circumference in absolute terms but a
smaller ratio of head circumferences to abdominal circum-
ference (LoE 2).
In the international literature of the last 10 years there is
no agreement on the cut-off percentile of the head circum-
ference required for the diagnosis of FAS. The German
guideline group could not reach consensus about this
criterion either. Therefore, for the diagnosis of FAS, the
3rd as well as the 10th percentile as cut-off for microcephaly
were accepted as a criterion for “Structural CNS
abnormalities”.
Because of the rather poor evidence and the lack of validity
criteria of the existing, mostly magnet resonance imaging,
studies about structural CNS abnormalities (e.g. volume re-
ductions of the grey and white matter of the cerebrum and
cerebellum, caudate nucleus, putamen, cingular gyrus and
cerebrospinal fluid, as well as an increased thickness of the
cortex: e.g. Refs.23e28 LoE 4), the guideline group concluded
that for the time being structural CNS abnormalities other
than microcephaly cannot be accepted as criteria for the
diagnosis of FAS in children and adolescents.3.7. Background information on the seventh key
recommendation: importance of confirmation of maternal
alcohol consumption during pregnancy
In 2010 Burd et al.29 examined in a retrospective cohort study
(LoE 3b) how important confirmed maternal alcohol con-
sumption is for correctly diagnosing FAS. The results show that
if alcohol use during pregnancy could not be confirmed, FAS
was diagnosed with a higher sensitivity (89% non-confirmed
versus 85% confirmed alcohol use) and a lower specificity
(71.1%versus 82.4%). Thus, comparedwith confirmedmaternal
alcohol use, there is a lower number of false negative and a
slightly greater number of false positive diagnoses. Because the
guideline group felt that todate a great numberof childrenwith
FAS in Germany remains unrecognized the guideline group
accepted the lower specificity of the diagnostic criterion “non-
confirmed alcohol consumption” and concluded that the
confirmation of maternal alcohol consumption is not essential
for the diagnosis of FAS when all other diagnostic criteria,
especially the FAS facial phenotype, are present.4. Discussion
Many professionals in the German health system, even phy-
sicians and psychologists, never heard systematically of FAS
in their professional training and have no structured diag-
nostic pathway available. Therefore they often fail to take the
possibility of FAS into consideration when assessing children
with developmental disorders. In Germany a considerable
number of FAS cases remain unrecognized even though the
patients do show multiple signs and symptoms typical for
FAS. As a result, those patients and families aremissing out on
adequate support and specific training.
The first aim of the German guideline group was to objec-
tively identify evidence-based diagnostic criteria for children
and adolescents with FAS which are presented in this article.
It is difficult to set up studies for the diagnosis of FAS that
are well designed and of high methodological quality.
One reason is that such studies rely on subjective informa-
tion on alcohol use obtained from the mothers rather than on
objective measures. This information may be influenced by
social desirability biasand recall biaswhen thepregnancydates
back a longer time. But even objective values in the maternal
blood such as carbohydrate-deficient transferrin or gamma-
glutamyl transferase may fail to detect alcohol use in early
pregnancy when the mother is abstinent in the last months of
pregnancy. Future research will show if measurement of fatty
acid ethyl esters and ethyl glucuronide in meconium is able to
quantify the exposure to ethanol during pregnancy.30
In the literature the diagnostic criteria of FAS are often
validated in children who already have been diagnosed with
FAS earlier. Thus there is no independent reliable reference
standard and a risk of incorporation bias. The earlier diagnosis
of FAS is based on various diagnostic instruments (e.g. IOM
criteria or 4-digit-diagnostic code) with different diagnostic
criteria and cut-offs (percentile of head circumference, num-
ber of facial anomalies, consideration of functional abnor-
malities of the central nervous system) and therefore does not
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patient and for each study.
Despite these methodological limitations, the German
guideline group determined explicit diagnostic criteria for FAS
in children and adolescents based on the evidence assessed
literature of the last 10 years and the consensus of the
multidisciplinary guideline group.
As the evidence levels of the publications used for our
guideline recommendations are partly still low we must
continue to be very circumspect in making a diagnosis of FAS
until such time that there is sufficiently robust research work
to support it.
FAS must be diagnosed with the highest level of medical
and ethical responsibility.
One reason is that the assessment of alcohol consumption
during pregnancy remains difficult. On the one hand, many
physicians or other medical professionals hesitate asking the
mothers about alcohol use because any such question may
upset themother’s trust to the point of breaking off contact. On
the other hand,manymothersmay not truthfully answer such
questions because they fear that admitting their true drinking
habitsmaysocially stigmatize them.Sincemanyof thechildren
with FAS in Germany live in adoptive or foster families the
history of the biological parents is often rudimentary. Therefore
the guideline group consented that the confirmation of
maternal alcohol use is not a prerequisite for the diagnosis of
FAS especiallywhenhighly sensitive facial featuresare present.
Another reason for difficulties in diagnosing FAS is that
some characteristics of the affected patientsmay change with
increasing age. The facial features and the growth deficits areFig. 4 e Pocket Guide FAtypically found in childhood, but can be less prominent in
adolescence or adulthood. In early childhood patients with
FAS often show only few or no functional CNS abnormalities.
By contrast, most of the adolescents with FAS have deficits in
behavior, attention and executive functions. Therefore the
diagnosis of FAS depends on an experienced developmental
assessment in very early childhood and on a complex neuro-
psychological assessment during later childhood, adolescence
and adulthood. For evaluation of the functional CNS abnor-
malities, neuropsychological tests and instruments were
evaluated regarding quality criteria (standardization, reli-
ability and validity) and adequate psychological instruments
were proposed for the assessment of each typically affected
neuropsychological subdomain in children and adolescents
with FAS in Germany.
The second aim of the guideline group was to improve
awareness and knowledge among health professionals about
the typical characteristics and deficits of children and ado-
lescents with FAS. Evidence based knowledge about the
diagnosis of fetal alcohol syndrome should be as ubiquitous as
the use of this drug is in our alcohol permissive societies.
At present the diagnostic capacity available in Germany is
not adequate tomeet the needs for diagnosis of FAS. Attention
to FASD in the training programs in Germany (Pediatrics,
Neuropediatrics, Neurology, Psychiatry, Psychology, Social
Workers, etc.) should be increased to be sure that appropriate
staffing requirements for diagnosis of FAS can be achieved.
Effective education of the German society about the life-
long negative consequences of maternal alcohol consumption
during pregnancy can only succeed with the help ofS (example pages).
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health and social system.
For practical clinical use of the diagnostic criteria the
following material was developed:
Pocket Guide FAS: an algorithm shows the diagnostic process of
children with suspected FAS at a glance. For each of the four
diagnostic fields differential diagnosis is listed. The Pocket
Guide also includes web-links for further information
regarding prevention of alcohol use during pregnancy and
support for affected families. Example pages are depicted in
Fig. 4. The Pocket Guide FAS can be downloaded as ePub.
Due to the limited available evidence these guideline rec-
ommendations are restricted to the full clinical picture of fetal
alcohol syndrome in children and adolescents.
The guideline group is fully aware of the fact that the other
fetal alcohol spectrum disorders (FASD), which have an esti-
mated ten times higher prevalence than FAS, are currently
excluded. As the diagnosis of FASD is much more difficult
because the affected patients may have a quite normal
physical appearance, and as these patients often do have the
same problems in everyday life as do patients with FAS,
further research is needed.
Another limitation of our guideline is that it only addresses
the diagnosis of FAS and does not propose any recommen-
dations for the adequate treatment of patients with FAS.
Defining the diagnostic approach to FAS is only seen as a
first but necessary step to avoid developmental mis-
conceptions caused by neglecting alcohol as an irreversible
toxic determiner of development. The German guideline is
only tackling the tip of the iceberg.
The development of evidence-based guidelines for the
treatment and support of affected children and their families
is urgently needed.
Furthermore, the far-reaching negative consequences of
intrauterine alcohol exposure in adult life including the
inability to live and work independently should also be given
attention in future research and guidelines.
Other points for future consideration in German research
are adequate methods to screen for prenatal alcohol exposure
in prenatal care and substance abuse treatment programs and
to screen for FAS in schools, pediatric clinics, clinics for
developmental medicine, special education programs, foster
care programs and in Juvenile Justice programs.
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